Page last updated: 2024-08-21

reticulin and Enlarged Spleen

reticulin has been researched along with Enlarged Spleen in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19907 (53.85)18.7374
1990's2 (15.38)18.2507
2000's0 (0.00)29.6817
2010's4 (30.77)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andraos, R; Baffert, F; Cozens, R; Dammassa, E; Dölemeyer, A; Ebel, N; Evrot, E; Hofmann, F; Murakami, M; Qian, Z; Radimerski, T; Roelli, C; Romanet, V; Sterker, D1
Brynes, RK; Moschiano, E; O'Connell, C; O'Neill, C; Siddiqi, I; Vergara-Lluri, M1
Ataya, R; Bertuch, AA; DeLario, MR; Lopez-Terrada, D; Sheehan, AM; Vega, C; Venkateswaran, L; Webb, CR1
Baskin, R; Bisht, KS; Cogle, CR; Gali, M; Keserű, GM; Kirabo, A; Park, SO; Reinhard, MK; Sayeski, PP; Wamsley, HL; Zhao, ZJ1
KAKIZAKI, G1
Choi, E; del Castillo, J; Hunt, P; Kaufman, S; Kinstler, O; Kirley, T; Senaldi, G; Sheridan, WP; Tarpley, J; Ulich, TR; Yin, S1
Basara, NM; Colović, MD; Janković, GM; Janosević, S; Vidović, AD; Wiernik, PH1
Evans, DI1
Reid, MM; Wallis, JP1
Dalal, BI; Freier, L; Israels, LG; Johnston, JB; Merry, CC1
Neiman, RS; Wolf, BC1
Catovsky, D; Galton, DA; Harrison, CV; Pettit, JE; Spiers, AS1
Pegrum, GD; Risdon, RA1

Other Studies

13 other study(ies) available for reticulin and Enlarged Spleen

ArticleYear
JAK1/2 and Pan-deacetylase inhibitor combination therapy yields improved efficacy in preclinical mouse models of JAK2V617F-driven disease.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Nov-15, Volume: 19, Issue:22

    Topics: Acetylation; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Disease Models, Animal; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Hydroxamic Acids; Indoles; Janus Kinase 1; Janus Kinase 2; Mice; Nitriles; Panobinostat; Polycythemia Vera; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Reticulin; Spleen; Splenomegaly; STAT5 Transcription Factor; Thrombocytosis

2013
Pegylated interferon for the treatment of early myelofibrosis: correlation of serial laboratory studies with response to therapy.
    Annals of hematology, 2016, Volume: 95, Issue:5

    Topics: Aged; Aged, 80 and over; Anemia; Biomarkers; Bone Marrow; Bone Marrow Examination; Disease Progression; Drug Evaluation; Female; Hemoglobins; Humans; Interferon alpha-2; Interferon-alpha; L-Lactate Dehydrogenase; Male; Middle Aged; Polycythemia Vera; Polyethylene Glycols; Primary Myelofibrosis; Recombinant Proteins; Reticulin; Single-Blind Method; Splenomegaly; Thrombocythemia, Essential

2016
Clinical, histopathologic, and genetic features of pediatric primary myelofibrosis--an entity different from adults.
    American journal of hematology, 2012, Volume: 87, Issue:5

    Topics: Adolescent; Age of Onset; Anemia, Myelophthisic; Bone Marrow; Bone Marrow Examination; Child; Child, Preschool; Collagen; Disease Progression; DNA Mutational Analysis; Eosinophilia; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Janus Kinase 2; Male; Mutation, Missense; Postoperative Complications; Primary Myelofibrosis; Receptors, Thrombopoietin; Remission, Spontaneous; Reticulin; Retrospective Studies; Splenomegaly; Staining and Labeling; Treatment Outcome

2012
The small molecule inhibitor G6 significantly reduces bone marrow fibrosis and the mutant burden in a mouse model of Jak2-mediated myelofibrosis.
    The American journal of pathology, 2012, Volume: 181, Issue:3

    Topics: Amino Acid Substitution; Animals; Bone Marrow; Disease Models, Animal; Hematopoiesis, Extramedullary; Humans; Hyperplasia; Janus Kinase 2; Megakaryocytes; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myeloid Cells; Phosphorylation; Primary Myelofibrosis; Protein Kinase Inhibitors; Reticulin; Small Molecule Libraries; Spleen; Splenomegaly; STAT5 Transcription Factor; Stilbenes

2012
ARCHITECTURE OF RETICULIN FIBERS OF THE SPLEEN IN BANTI'S SYNDROME.
    The Tohoku journal of experimental medicine, 1964, May-25, Volume: 82

    Topics: Anemia; Connective Tissue; Histology; Humans; Hypersplenism; Hypertension; Hypertension, Portal; Idiopathic Noncirrhotic Portal Hypertension; Liver Cirrhosis; Mononuclear Phagocyte System; Pancytopenia; Pathology; Reticulin; Spleen; Splenomegaly

1964
Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice.
    Blood, 1996, Jun-15, Volume: 87, Issue:12

    Topics: Anemia; Animals; Bone Marrow; Cell Count; Cell Differentiation; Hematopoietic Stem Cells; Humans; Hyperplasia; Injections, Intraperitoneal; Megakaryocytes; Mice; Mice, Inbred BALB C; Polyethylene Glycols; Primary Myelofibrosis; Recombinant Fusion Proteins; Recombinant Proteins; Reticulin; Splenomegaly; Thrombocytosis; Thrombopoietin

1996
Circulating haemopoietic progenitor cells in primary and secondary myelofibrosis: relation to collagen and reticulin fibrosis.
    European journal of haematology, 1999, Volume: 62, Issue:3

    Topics: Adult; Aged; Blood Cell Count; Bone Marrow; Collagen; Colony-Forming Units Assay; Female; Hematologic Neoplasms; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Primary Myelofibrosis; Prospective Studies; Reticulin; Splenomegaly

1999
Acute myelofibrosis in children with Down's syndrome.
    Archives of disease in childhood, 1975, Volume: 50, Issue:6

    Topics: Acute Disease; Adult; Anemia; Autopsy; Bone Marrow; Bone Marrow Examination; Death; Down Syndrome; Female; Humans; Infant; Infant, Newborn; Leukemia, Lymphoid; Leukemia, Myeloid; Male; Megakaryocytes; Primary Myelofibrosis; Reticulin; Splenomegaly; Thrombocythemia, Essential

1975
Bone marrow fibrosis in childhood acute lymphoblastic leukaemia.
    Journal of clinical pathology, 1989, Volume: 42, Issue:12

    Topics: Adolescent; Antigens, Differentiation, B-Lymphocyte; Antigens, Differentiation, T-Lymphocyte; Bone Marrow; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Myelofibrosis; Reticulin; Splenomegaly

1989
Peripheral blood and bone marrow changes following 2'-deoxycoformycin therapy in hairy cell leukemia. Results of 200 weeks' follow-up.
    Cancer, 1989, Jan-01, Volume: 63, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Coformycin; Female; Follow-Up Studies; Hemoglobins; Humans; Leukemia, Hairy Cell; Leukocyte Count; Male; Middle Aged; Pentostatin; Remission Induction; Reticulin; Ribonucleosides; Splenomegaly

1989
Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly.
    Blood, 1985, Volume: 65, Issue:4

    Topics: Adult; Aged; Bone Marrow Examination; Female; Hematopoietic Stem Cells; Humans; Male; Megakaryocytes; Middle Aged; Organ Size; Primary Myelofibrosis; Reticulin; Spleen; Splenomegaly

1985
Leukaemic reticuloendotheliosis ('Hairy' cell leukaemia): a distinct clinico-pathological entity.
    British journal of haematology, 1974, Volume: 26, Issue:1

    Topics: Acid Phosphatase; Adult; Anemia, Aplastic; Blood Cell Count; Bone Marrow; Cyclophosphamide; Cytoplasm; Female; Hepatomegaly; Histocytochemistry; Humans; Leukemia; Liver; Liver Function Tests; Lymph Nodes; Lymphatic Diseases; Male; Microscopy, Electron; Middle Aged; Prednisone; Reticulin; Ribosomes; Spleen; Splenectomy; Splenomegaly

1974
The haematological and histological findings in 18 patients with clinical features resembling those of myelofibrosis.
    British journal of haematology, 1970, Volume: 18, Issue:4

    Topics: Aged; Alkaline Phosphatase; Bone Marrow Examination; Erythropoiesis; Female; Humans; Leukocyte Count; Leukocytosis; Male; Middle Aged; Primary Myelofibrosis; Reticulin; Splenomegaly

1970